Age and interval for screening mammography: Whom do you believe?

The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on simi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in surgical oncology 1996-09, Vol.12 (5), p.281-289
Hauptverfasser: Venta, Luz A., Goodhartz, Lori Ann
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 289
container_issue 5
container_start_page 281
container_title Seminars in surgical oncology
container_volume 12
creator Venta, Luz A.
Goodhartz, Lori Ann
description The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1098-2388(199609/10)12:5<281::AID-SSU2>3.0.CO;2-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78449456</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78449456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4042-1e9f8393d03b6fef2083062a24f4f1843a1626eb4dd7a3180d54f529f82d6c43</originalsourceid><addsrcrecordid>eNqFkE1vEzEQhi0EKqHwE5B8Qu1hU3-vHRAlLKVEKs0hRelt5Oza6cJ-BDsp5N93t4nCASROo9HMPO_oQeickiElhJ2dzCbZ5JQSoxPGtT6hxihizig5pWwk3zFNR6Px5FMym31j7_mQDLPpW5aYJ2hwuHmKBjqVKiGCp8_Rixi_E0KpZPwIHWmdck7lAH0YLx22TYHLZu3Cva2wbwOOeXCuKZslrm1dt8tgV3fbEZ7ftTUuWrxtN3jhqtLdu_OX6Jm3VXSv9vUY3Xy-uMm-JFfTy0k2vkpyQQRLqDNec8MLwhfKO8-I5kQxy4QXnmrBLVVMuYUoitRyqkkhhZesO2KFygU_Rm922FVof25cXENdxtxVlW1cu4mQaiGMkKpbnO8W89DGGJyHVShrG7ZACfRqAXq10GuCXhPs1D6OGUjo1AJ0aqFXCxwIZFNgYDry6_0Lm0XtigN37_JP8q-yctu_Yv-f-o_Qx74jJztyGdfu94Fsww9QKU8lzK8v4evtNb0l6Rw-8gcUQ6JV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78449456</pqid></control><display><type>article</type><title>Age and interval for screening mammography: Whom do you believe?</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Venta, Luz A. ; Goodhartz, Lori Ann</creator><creatorcontrib>Venta, Luz A. ; Goodhartz, Lori Ann</creatorcontrib><description>The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.</description><identifier>ISSN: 8756-0437</identifier><identifier>EISSN: 1098-2388</identifier><identifier>DOI: 10.1002/(SICI)1098-2388(199609/10)12:5&lt;281::AID-SSU2&gt;3.0.CO;2-9</identifier><identifier>PMID: 8873315</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Age Factors ; breast neoplasms ; Breast Neoplasms - diagnostic imaging ; Breast Neoplasms - mortality ; Breast Neoplasms - prevention &amp; control ; epidemiology ; Female ; Humans ; Incidence ; mammography ; Mammography - methods ; Mass Screening - methods ; Middle Aged ; Outcome Assessment (Health Care) ; Practice Guidelines as Topic ; public health ; Time Factors</subject><ispartof>Seminars in surgical oncology, 1996-09, Vol.12 (5), p.281-289</ispartof><rights>Copyright © 1996 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4042-1e9f8393d03b6fef2083062a24f4f1843a1626eb4dd7a3180d54f529f82d6c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2388%28199609%2F10%2912%3A5%3C281%3A%3AAID-SSU2%3E3.0.CO%3B2-9$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2388%28199609%2F10%2912%3A5%3C281%3A%3AAID-SSU2%3E3.0.CO%3B2-9$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8873315$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Venta, Luz A.</creatorcontrib><creatorcontrib>Goodhartz, Lori Ann</creatorcontrib><title>Age and interval for screening mammography: Whom do you believe?</title><title>Seminars in surgical oncology</title><addtitle>Semin. Surg. Oncol</addtitle><description>The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Age Factors</subject><subject>breast neoplasms</subject><subject>Breast Neoplasms - diagnostic imaging</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - prevention &amp; control</subject><subject>epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>mammography</subject><subject>Mammography - methods</subject><subject>Mass Screening - methods</subject><subject>Middle Aged</subject><subject>Outcome Assessment (Health Care)</subject><subject>Practice Guidelines as Topic</subject><subject>public health</subject><subject>Time Factors</subject><issn>8756-0437</issn><issn>1098-2388</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1vEzEQhi0EKqHwE5B8Qu1hU3-vHRAlLKVEKs0hRelt5Oza6cJ-BDsp5N93t4nCASROo9HMPO_oQeickiElhJ2dzCbZ5JQSoxPGtT6hxihizig5pWwk3zFNR6Px5FMym31j7_mQDLPpW5aYJ2hwuHmKBjqVKiGCp8_Rixi_E0KpZPwIHWmdck7lAH0YLx22TYHLZu3Cva2wbwOOeXCuKZslrm1dt8tgV3fbEZ7ftTUuWrxtN3jhqtLdu_OX6Jm3VXSv9vUY3Xy-uMm-JFfTy0k2vkpyQQRLqDNec8MLwhfKO8-I5kQxy4QXnmrBLVVMuYUoitRyqkkhhZesO2KFygU_Rm922FVof25cXENdxtxVlW1cu4mQaiGMkKpbnO8W89DGGJyHVShrG7ZACfRqAXq10GuCXhPs1D6OGUjo1AJ0aqFXCxwIZFNgYDry6_0Lm0XtigN37_JP8q-yctu_Yv-f-o_Qx74jJztyGdfu94Fsww9QKU8lzK8v4evtNb0l6Rw-8gcUQ6JV</recordid><startdate>199609</startdate><enddate>199609</enddate><creator>Venta, Luz A.</creator><creator>Goodhartz, Lori Ann</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199609</creationdate><title>Age and interval for screening mammography: Whom do you believe?</title><author>Venta, Luz A. ; Goodhartz, Lori Ann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4042-1e9f8393d03b6fef2083062a24f4f1843a1626eb4dd7a3180d54f529f82d6c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>breast neoplasms</topic><topic>Breast Neoplasms - diagnostic imaging</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - prevention &amp; control</topic><topic>epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>mammography</topic><topic>Mammography - methods</topic><topic>Mass Screening - methods</topic><topic>Middle Aged</topic><topic>Outcome Assessment (Health Care)</topic><topic>Practice Guidelines as Topic</topic><topic>public health</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Venta, Luz A.</creatorcontrib><creatorcontrib>Goodhartz, Lori Ann</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Venta, Luz A.</au><au>Goodhartz, Lori Ann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age and interval for screening mammography: Whom do you believe?</atitle><jtitle>Seminars in surgical oncology</jtitle><addtitle>Semin. Surg. Oncol</addtitle><date>1996-09</date><risdate>1996</risdate><volume>12</volume><issue>5</issue><spage>281</spage><epage>289</epage><pages>281-289</pages><issn>8756-0437</issn><eissn>1098-2388</eissn><abstract>The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>8873315</pmid><doi>10.1002/(SICI)1098-2388(199609/10)12:5&lt;281::AID-SSU2&gt;3.0.CO;2-9</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 8756-0437
ispartof Seminars in surgical oncology, 1996-09, Vol.12 (5), p.281-289
issn 8756-0437
1098-2388
language eng
recordid cdi_proquest_miscellaneous_78449456
source MEDLINE; Wiley Online Library Journals
subjects Adult
Age Factors
breast neoplasms
Breast Neoplasms - diagnostic imaging
Breast Neoplasms - mortality
Breast Neoplasms - prevention & control
epidemiology
Female
Humans
Incidence
mammography
Mammography - methods
Mass Screening - methods
Middle Aged
Outcome Assessment (Health Care)
Practice Guidelines as Topic
public health
Time Factors
title Age and interval for screening mammography: Whom do you believe?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A33%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age%20and%20interval%20for%20screening%20mammography:%20Whom%20do%20you%20believe?&rft.jtitle=Seminars%20in%20surgical%20oncology&rft.au=Venta,%20Luz%20A.&rft.date=1996-09&rft.volume=12&rft.issue=5&rft.spage=281&rft.epage=289&rft.pages=281-289&rft.issn=8756-0437&rft.eissn=1098-2388&rft_id=info:doi/10.1002/(SICI)1098-2388(199609/10)12:5%3C281::AID-SSU2%3E3.0.CO;2-9&rft_dat=%3Cproquest_cross%3E78449456%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78449456&rft_id=info:pmid/8873315&rfr_iscdi=true